Delivery Order SPE2DX22D0010-SPE2D825FBC54
Award Date
11/11/24
Potential Completion Date
11/12/24
Potential Value
$2.3K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,638.54 firm fixed-price delivery order is for the supply of 100 tablets of 18 mg Methylphenidate Extended Release, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of March 10, 2025 and was awarded on March 7, 2025....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,457.76 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of 100 units of the 36 mg extended-release tablet form of the drug methylphenidate, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The award has a period of performance through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.22 firm-fixed-price delivery order is for the supply of 4,566,504,596 tablets of 27mg extended-release methylphenidate, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,414.83, is for the delivery of 18 mg extended-release methylphenidate tablets, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has a period of performance through October 24, 2024 and is structured as a firm fixed-price...
This federal contract award, valued at $2,845.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of 36 mg Methylphenidate Extended Release, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of February 5, 2025. The award is not associated with a...
This federal contract award, valued at $6,494.92, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of METHYLPHENIDATE ER TABS 54MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,867.90 firm-fixed-price delivery order is for the supply of 100 tablets of 18 mg Methylphenidate Extended Release, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
This federal contract award, valued at $1,409.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of 54 mg Methylphenidate Extended Release, a medication used to treat ADHD. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 18 mg Methylphenidate Extended-Release tablets, a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD). The contract has a firm fixed price of $1,162.20 and a completion date of October 29, 2024. This award is a delivery order under a larger...
This federal contract award, valued at $1,327.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100 tablets of 18 mg methylphenidate extended-release, a medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD). The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. No set-aside designation was...